Friday, June 27 11:38:01
The Trinity Biomedical Sciences Institute (TBSI) has created 119 jobs over the past two years, it said today.
It partnered with 76 companies to undertake world-class research that is helping to tackle some of society's most significant health challenges.
The figures emerged today at an event to launch TBSI's first progress report, held in partnership with Science Foundation Ireland (SFI), Ireland's research funding body.
TBSI is a key outcome of Trinity's Innovation Alliance with University College Dublin. It was supported by the Government's Programme for Research in Third-Level Institutions (PRTLI) which is administered by the Higher Education Authority.
Trinity's Provost, Dr Patrick Prendergast, said TBSI's breakthrough work has been enhancing patient care and pushing the boundaries of biomedical science since it opened in 2011.
"TBSI brings together an interdisciplinary mix of talent from across Trinity, carrying out world-class research in drug discovery, immunology, and medical device technologies. The work of Trinity researchers in these areas has placed Ireland among the world's leading places for biomedical science. The scientific breakthroughs achieved in TBSI are having a profound impact on patient care, and creating value for Ireland and society generally," said Dr Prendergast.